BioasisUS's Recent Posts
Title ▲ Rating Company Posted on
First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments 4 BIOASIS TECHNOLOGIES INC Oct 29, 2018 08:01AM
First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments 4 BIOASIS TECHNOLOGIES INC Oct 29, 2018 08:10AM
Link to Bioasis PR re: quarterly financial statements and MD&A for the period ended Nov. 30, 2017 2 BIOASIS TECHNOLOGIES INC Jan 30, 2018 11:56AM
Re: Delivery peptide conjugates of Trastuzumab 1 BIOASIS TECHNOLOGIES INC Mar 21, 2018 04:52AM
Re: Dr. Deborah Rathjen, CEO & Managing Director of Bionomics Appointed Chair of the Bioasis Board of Directors 1 BIOASIS TECHNOLOGIES INC Mar 21, 2018 09:55AM
Syntimmune Picks Up Vertex SVP Saltarelli for CMO 3 BIOASIS TECHNOLOGIES INC Jul 09, 2018 05:13PM